Skip to content

Zai Lab Ltd

ZLAB

CIK 0001704292 · Pharmaceutical Preparations · Nasdaq

  • Zai Lab Ltd (until 2026-06-17)
← back to feed
Revenue (TTM)
$425.65M
+15.0% YoY Q1 Mar 2026
Net Income (TTM)
−$176.14M
+31.7% YoY Q1 Mar 2026
EPS Diluted (TTM)
−$0.16
+38.5% YoY Q1 Mar 2026
Gross Margin
0.0%
Q1 Mar 2026
Operating Margin
-53.9%
Q1 Mar 2026
Net Margin
-41.4%
Q1 Mar 2026
Free Cash Flow (TTM)
−$240.22M
Q1 Mar 2026
Cash
$651.32M
Q1 Mar 2026
Total Debt
$213.82M
Q1 Mar 2026
Shares Outstanding
88.59M sh
Q1 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings